Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sabine Eichinger

Showing results (41-50 of 105) with videos related to

Pageof 11
Sort By:
JAMA|July 27, 2006
Identification of patients at low risk for recurrent venous thromboembolism by measuring thrombin generationGregor Hron, Marietta Kollars, Bernd R Binder, et al.
Thrombosis Research|August 5, 2020
Recurrent venous thromboembolism during anticoagulation with edoxaban or warfarin: A post hoc analysis of the Hokusai-VTE trialSabine Eichinger, Min Lin, Minggao Shi, et al.
The New England Journal of Medicine|June 18, 2004
The risk of recurrent venous thromboembolism in men and womenPaul A Kyrle, Erich Minar, Christine Bialonczyk, et al.
The American Journal of the Medical Sciences|March 30, 2021
MicroRNA Signatures in Plasma of Patients With Venous Thrombosis: A Preliminary ReportJessica Gabler, José Basílio, Oskar Steinbrecher, et al.
Haematologica|August 2, 2007
Low vitamin B6 levels and the risk of recurrent venous thromboembolismGregor Hron, Rossana Lombardi, Sabine Eichinger, et al.
Thrombosis and Haemostasis|March 18, 2006
Marburg I polymorphism of factor VII-activating protease and risk of recurrent venous thromboembolismTalin Gulesserian, Gregor Hron, Georg Endler, et al.
Plos One|June 16, 2012
Hematocrit and the risk of recurrent venous thrombosis: a prospective cohort studyLisbeth Eischer, Verena Tscholl, Georg Heinze, et al.
Haematologica|January 25, 2020
Clinical and laboratory characteristics of cyclic thrombocytopenia: an observational studyOskar Steinbrecher, Mirjana Mitrovic, Lisbeth Eischer, et al.
European Heart Journal|May 27, 2009
Regulation of PAR-1 in patients undergoing percutaneous coronary intervention: effects of unfractionated heparin and bivalirudinRoza Badr Eslam, Nina Reiter, Alexandra Kaider, et al.
Frontiers in Pharmacology|December 29, 2022
Plasma levels of platelet-enriched microRNAs change during antiplatelet therapy in healthy subjectsTeresa L Krammer, Marietta Kollars, Paul A Kyrle, et al.
Pageof 11

Showing results (41-50 of 105) with videos related to

Sort By:
Pageof 11
JAMA|July 27, 2006
Identification of patients at low risk for recurrent venous thromboembolism by measuring thrombin generationGregor Hron, Marietta Kollars, Bernd R Binder, et al.
Thrombosis Research|August 5, 2020
Recurrent venous thromboembolism during anticoagulation with edoxaban or warfarin: A post hoc analysis of the Hokusai-VTE trialSabine Eichinger, Min Lin, Minggao Shi, et al.
The New England Journal of Medicine|June 18, 2004
The risk of recurrent venous thromboembolism in men and womenPaul A Kyrle, Erich Minar, Christine Bialonczyk, et al.
The American Journal of the Medical Sciences|March 30, 2021
MicroRNA Signatures in Plasma of Patients With Venous Thrombosis: A Preliminary ReportJessica Gabler, José Basílio, Oskar Steinbrecher, et al.
Haematologica|August 2, 2007
Low vitamin B6 levels and the risk of recurrent venous thromboembolismGregor Hron, Rossana Lombardi, Sabine Eichinger, et al.
Thrombosis and Haemostasis|March 18, 2006
Marburg I polymorphism of factor VII-activating protease and risk of recurrent venous thromboembolismTalin Gulesserian, Gregor Hron, Georg Endler, et al.
Plos One|June 16, 2012
Hematocrit and the risk of recurrent venous thrombosis: a prospective cohort studyLisbeth Eischer, Verena Tscholl, Georg Heinze, et al.
Haematologica|January 25, 2020
Clinical and laboratory characteristics of cyclic thrombocytopenia: an observational studyOskar Steinbrecher, Mirjana Mitrovic, Lisbeth Eischer, et al.
European Heart Journal|May 27, 2009
Regulation of PAR-1 in patients undergoing percutaneous coronary intervention: effects of unfractionated heparin and bivalirudinRoza Badr Eslam, Nina Reiter, Alexandra Kaider, et al.
Frontiers in Pharmacology|December 29, 2022
Plasma levels of platelet-enriched microRNAs change during antiplatelet therapy in healthy subjectsTeresa L Krammer, Marietta Kollars, Paul A Kyrle, et al.
Pageof 11